Tetrabenazine Tablets
This product is indicated for the treatment of chorea in Huntington's disease. Chorea in Huntington's disease is a rare autosomal dominant neurodegenerative disorder affecting the central nervous system (included in the 2018 China's First List of Rare Diseases). Symptoms include involuntary dance-like movements, cognitive impairment and mental disorders. Tetrabenazine is the world's first drug used to treat chorea in Huntington's disease.
Product Category：
Product Description
[Product Name] Dingruixin®
[Generic Name] Tetrabenazine Tablets
[Approval No.] JYHS2101037
[Specification] JX20230126
[Dosage and Administration] The initial dose is 12.5 mg once daily in the morning. One week later, the daily dose is increased to 25 mg (12.5 mg twice daily).
[Indications] Chorea in Huntington's disease.
[Strength] 25 mg×112 tablets/carton
[Storage] Store in airtight containers below 25°C.
[Shelf Life] 24 months
[Manufacturer] Dr. Reddy's Laboratories Ltd.
[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Related Products
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No. 1001, Xueyuan Avenue, Changyuan Community, Taoyuan Street, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED